Clinical Trial

Targeting Heavy Alcohol Use with Naltrexone

Study Description

Say When: Targeting Heavy Alcohol Use With Naltrexone Among MSM

This is a double-blind, placebo-controlled trial of 120 binge-drinking MSM to 12 weeks of naltrexone 50mg, to be taken in anticipation of heavy drinking. Ethnically and racially diverse participants will be recruited using Respondent Driven Sampling as well as active field recruitment. MSM will be seen weekly for alcohol-metabolite urine testing, study drug dispensing, and brief counseling for alcohol use. Safety assessments and behavioral surveys will be completed monthly.

Location

Locations Selected Location

Methods

Pharmaceutical medication involved Pharmaceutical medication involved
Patients and healthy individuals accepted Patients and healthy individuals accepted

Drug - Placebo

Drug - Naltrexone

Additional Information

Official Study Title

Say When: Targeting Heavy Alcohol Use With Naltrexone Among MSM

Clinical Trial ID

NCT02330419

ParticipAid ID

6dB82a